Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target reduced by stock analysts at BMO Capital Markets from $24.00 to $20.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has a "market perform" rating on the stock. BMO Capital Markets's price objective would indicate a potential upside of 5.62% from the company's current price.
A number of other equities research analysts have also recently weighed in on the stock. UBS Group lifted their price objective on shares of Bath & Body Works from $17.00 to $22.00 and gave the company a "neutral" rating in a research note on Friday, November 13th. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Wednesday, September 16th. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 target price for the company in a research report on Tuesday, August 18th. Morgan Stanley lowered their target price on shares of Bath & Body Works from $22.00 to $21.00 and set an "equal weight" rating on the stock in a research note on Friday. Finally, Barclays dropped their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 27th. Four research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $22.27.
Get Our Latest Analysis on Bath & Body Works
Bath & Body Works Trading Up 0.1%
BBWI traded up $0.03 during trading hours on Friday, hitting $18.93. The company's stock had a trading volume of 1,828,155 shares, compared to its average volume of 6,023,616. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $24.94. The firm has a market capitalization of $3.82 billion, a PE ratio of 4.96, a PEG ratio of 0.93 and a beta of 1.31. The company has a 50-day simple moving average of $19.24 and a 200 day simple moving average of $19.77.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm's quarterly revenue was down 1.1% on a year-over-year basis. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Research analysts expect that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Bath & Body Works
A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. Algert Global LLC lifted its stake in Bath & Body Works by 36.0% during the third quarter. Algert Global LLC now owns 684,287 shares of the company's stock valued at $10,894,000 after purchasing an additional 181,023 shares during the last quarter. Ancora Advisors LLC grew its position in Bath & Body Works by 107,891.7% in the third quarter. Ancora Advisors LLC now owns 12,959 shares of the company's stock worth $206,000 after buying an additional 12,947 shares during the last quarter. Readystate Asset Management LP increased its holdings in shares of Bath & Body Works by 408.8% in the third quarter. Readystate Asset Management LP now owns 579,712 shares of the company's stock valued at $9,229,000 after buying an additional 465,780 shares in the last quarter. Ares Systematic Credit Ltd bought a new position in shares of Bath & Body Works in the third quarter valued at $442,000. Finally, Saba Capital Management L.P. lifted its position in shares of Bath & Body Works by 784.2% during the 3rd quarter. Saba Capital Management L.P. now owns 84,111 shares of the company's stock valued at $1,339,000 after acquiring an additional 74,598 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.
Bath & Body Works News Summary
These are some of the BBWI news items that stood out recently:
- Positive Sentiment: Third-quarter adjusted EPS was $0.26, above the $0.12 consensus, and revenue of $1.58 billion topped expectations. The company also raised its full-year sales outlook, citing progress in digital and wholesale channels. Third-quarter results and updated outlook
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new seasonal offering, though the financial impact is not yet clear. Pantone collaboration announcement
- Negative Sentiment: The fourth-quarter EPS outlook of $1.41–$1.61 is below analysts’ $1.72 estimate, and revenue guidance also falls short of consensus at its upper end. Management warned of softer holiday sales; quarterly revenue and EPS were also below year-ago levels. This cautious near-term outlook may overshadow the earnings beat and higher full-year sales forecast. Holiday sales outlook
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.